Valeant Pharmaceuticals International stock price, VRX

Valeant Pharmaceuticals International stock chart:



Valeant Pharmaceuticals International close price: 13.59

Stock price forecast:

DOWN TO -13.39%
Target: 11.77

Total forecasts: 84
Reached: 38 (45.24%)

Total Win: 45.95 (479.32%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
No results found.

Showing 1-10 of 583 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-06-2613.5911.770000-00-00
2017-06-2513.5911.750000-00-00
2017-06-2413.5911.730000-00-00
2017-06-2313.5911.70000-00-00
2017-06-2213.5911.880000-00-00
2017-06-2113.5911.920000-00-00
2017-06-2013.5911.750000-00-00
2017-06-1913.5911.720000-00-00
2017-06-1813.5911.610000-00-00
2017-06-1713.5911.560000-00-00

Valeant Pharmaceuticals International latest news:


  • 06/19/2017 16:10:00

    BRIEF-Valeant appoints Arthur Shannon senior vice president, head of investor relations and communications

    June 19 (Reuters) - Valeant Pharmaceuticals International Inc-

  • 06/08/2017 14:14:16

    CANADA STOCKS-TSX ends higher as Valeant bounces, banks gain

    TORONTO, June 8 (Reuters) - Canada's main stock index ended higher on Thursday, helped by gains for banking stocks after the Bank of Canada said it considers the system robust and a jump in Valeant Pharmaceuticals after it announced an asset sale.

  • 06/08/2017 09:30:17

    Valeant Pharmaceuticals Plans to Sell iNova Segment


  • 05/11/2017 13:45:43

    Valeant stock jumps 8% after positive patent litigation developments

    Valeant Pharmaceuticals International Inc. shares jumped 8.2% at $13.71 on Thursday after favorable developments in patent litigation over its biggest drug, Xifaxan. Xifaxan treats irritable bowel disease and has brought in nearly $1 billion a year for the company, though sales have flagged more recently. Though the court documents in question are sealed, the court record did divulge a favorable ruling for Valeant on two key issues, said EvercoreISI analyst Umer Raffat. In addition, a 30-month stay on patent litigation has been extended, he said. Valeant shares have dropped 8.4% over the last three months, compared with a 3.4% rise in the S&P 500 . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 05/09/2017 14:16:51

    CANADA STOCKS-TSX dragged by banks and energy; Valeant, Home Capital surges

    TORONTO, May 9 (Reuters) - Canada's main stock index fell more than half a percent on Tuesday as bank and energy stocks led the market lower, but Valeant Pharmaceuticals International and Home Capital Group Inc stocks soared as investors cheered news from the companies.

  • 05/09/2017 07:51:42

    S&P 500, Nasdaq ump to intraday records on upbeat earnings

    U.S. stocks on Tuesday opened at or near record levels as investors appeared heartened by upbeat earnings reports and the easing of some of the market's near-term worries. The Dow Jones Industrial Average traded 22 points, or less than 0.1%, at 21,1033, the S&P 500 index gained about 3 points, or 0.1%, at 2,401, briefly eclipsing its intraday record of 2,401.36 set on Monday, while the Nasdaq Composite Index climbed 7 points, or 0.2%, at 6,116-a new intraday record for the tech-heavy index. A measure of market volatility, the CBOE Volatility Index , fell to a roughly 23-year low on Monday and threatened to hit its lowest level in history, according to FactSet. The VIX has been closely followed because it implies to some market participants that investors may be getting too complacent about the possibility of sharp dives in equities, after a monthslong rise that has taken them to repeated record levels. Meanwhile, the 10-year Treasury note yield [BX: TMUBMUSD10Y], which moves inversely to price, was at 2.40%, around the highest level in weeks for the benchmark bond. Shares of Office Depot Inc. , Valeant Pharmaceuticals International Inc. and Marriott International Inc. were all trading higher after reporting better-than-expected quarterly results. Moves for the markets come after one big geopolitical overhang subsided over the weekend, with the French presidency won by Emmanuel Macron, viewed as a pro-market candidate. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/13/2017 14:04:15

    Valeant, Sorrento Pharmaceuticals Tumble into Thursday’s 52-Week Low Club


  • 03/30/2017 02:29:34

    Ackman apologizes for Valeant losses, calls bet a mistake

    BOSTON (Reuters) - Billionaire hedge fund manager William Ackman has apologized to clients for betting on Valeant Pharmaceuticals International Inc , telling them he was "deeply and profoundly sorry"...

  • More trends:

    Valero Energy CorporationVLO | Valero Energy Partners LPVLP | ValhiVHI | Validus HoldingsVR | Valley National BancorpVLY | Valley National BancorpVLY.WS | Valley National BancorpVLY^A | Valmont IndustriesVMI | Valspar Corporation (The)VAL | VantivVNTV |